ESCAPELLE

This brand name is authorized in Croatia, Estonia, Hong Kong SAR China, Lithuania, Malta, Poland, Romania, South Africa.

Active ingredients

The drug ESCAPELLE contains one active pharmaceutical ingredient (API):

1	Levonorgestrel UNII 5W7SIA7YZW - LEVONORGESTREL
	The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest.
	Read more about Levonorgestrel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ESCAPELLE Tablet	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AD01	Levonorgestrel	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AD Emergency contraceptives
Discover more medicines within G03AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1134100
HK	Department of Health Drug Office	55811
HR	Agencija za lijekove i medicinske proizvode	HR-H-310795359, HR-H-311381977
LT	Valstybinė vaistų kontrolės tarnyba	1021308, 1067940, 1074488, 1080184, 1087893, 1092804
MT	Medicines Authority	MA1031/00301
PL	Rejestru Produktów Leczniczych	100158979, 100260353, 100304381, 100324797, 100342720, 100399476, 100413740, 100432937
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43332001
ZA	Health Products Regulatory Authority	41/21.8.2/0021